RedPath is a provider of specialized cancer diagnostic testing. The company utilizes a proprietary platform technology called PathFinder TG which integrates comprehensive molecular/genetic analysis with traditional microscopic cellular analysis to help pathologists make superior diagnostic determinations. The company markets its services to pathologists and oncologists to help evaluate and provide definitive diagnosis to suspicious or equivocal samples.